| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 27/08/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells | AMEX:IRBO | |
| 23/08/2007 | 13:00 | PR Newswire (US) | ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information | AMEX:IRBO | |
| 16/08/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook | AMEX:IRBO | |
| 07/08/2007 | 14:00 | PR Newswire (US) | ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. | AMEX:IRBO | |
| 23/07/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences, Inc. to Present Homspera(TM) at 2007 BARDA Industry Day | AMEX:IRBO | |
| 19/07/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences, Inc. and Virion Systems, Inc. Continue Testing Viprovex(R) and Tamiflu(R) as Possible Influenza Co-Trea | AMEX:IRBO | |
| 12/07/2007 | 15:16 | PR Newswire (US) | ULURU Inc. Announces Co-Development Agreement for Potential Advanced Wound Care Therapeutic | AMEX:IRBO | |
| 12/07/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences Announces Development Partnership With Uluru Inc. | AMEX:IRBO | |
| 07/05/2007 | 14:00 | PR Newswire (US) | IR BioSciences Announces Promising Data from Study of Its Compound Homspera | AMEX:IRBO | |
| 25/04/2007 | 16:07 | PR Newswire (US) | IR BioSciences Appoints Celgene Executive Dr. Robert Hariri to Its Board of Directors | AMEX:IRBO | |
| 20/03/2007 | 14:08 | PR Newswire (US) | ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent | AMEX:IRBO | |
| 14/03/2007 | 16:47 | PR Newswire (US) | IR BioSciences, Inc. Responds to the Recently Cancelled Acute Radiation Syndrome (ARS) RFP by DHHS | AMEX:IRBO | |
| 08/03/2007 | 16:11 | PR Newswire (US) | IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal | AMEX:IRBO | |
| 26/02/2007 | 13:00 | PR Newswire (US) | IR BioSciences Holdings, Inc. to Collaborate with Leading Clinical Services Company to Evaluate Radilex(TM) in Low-Level Radiati | AMEX:IRBO | |
| 09/02/2007 | 00:32 | PR Newswire (US) | /C O R R E C T I O N -- ImmuneRegen BioSciences, Inc./ | AMEX:IRBO | |
| 08/02/2007 | 14:00 | PR Newswire (US) | ImmuneRegen's Viprovex Demonstrates Immune Response Potential in Treatment of Avian Influenza and Spanish Flu | AMEX:IRBO | |
| 18/01/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences, Inc. Retains Battelle for Radiation and Infectious Disease Testing | AMEX:IRBO | |
| 16/01/2007 | 13:00 | PR Newswire (US) | ImmuneRegen Achieves Key Milestone in Testing of Potential Infectious Disease Treatment | AMEX:IRBO | |
| 09/01/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences, Inc. Demonstrates That Viprovex(TM) Is a Potential Treatment for Avian and Other Influenzas | AMEX:IRBO | |
| 04/01/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences, Inc. Announces First Study of Viprovex(TM) to Explore Adjuvant Capabilities in the Area of Pandemic Inf | AMEX:IRBO | |
| 03/01/2007 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences Appoints Hal Siegel, Ph.D. as Senior Director of Product Development & Regulatory Affairs | AMEX:IRBO | |
| 11/12/2006 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences Responds to Department of Health and Human Services Request for Information for Medical Countermeasures | AMEX:IRBO | |
| 07/12/2006 | 13:00 | PR Newswire (US) | ImmuneRegen BioSciences Closes Round of Funding | AMEX:IRBO | |
| 30/08/2006 | 14:30 | PR Newswire (US) | ImmuneRegen Begins Next Study With Oak Ridge National Laboratory (ORNL) | AMEX:IRBO | |
| 17/08/2006 | 14:00 | PR Newswire (US) | ImmuneRegen Announces Further Results From Anthrax Treatment Study | AMEX:IRBO | |
| 02/08/2006 | 14:00 | PR Newswire (US) | ImmuneRegen Product to be Tested as Defense to Potential Biological Weapon | AMEX:IRBO | |
| 31/07/2006 | 14:00 | PR Newswire (US) | Singapore's DSO National Laboratories to Study ImmuneRegen's Viprovex(TM) | AMEX:IRBO | |
| 24/07/2006 | 14:00 | PR Newswire (US) | NIH to Conduct Preclinical Evaluation of ImmuneRegen's Radilex(TM) | AMEX:IRBO | |
| 18/07/2006 | 17:50 | PR Newswire (US) | ImmuneRegen BioSciences, Inc. Appoints Investor Awareness, Inc. to Launch Investor Relations Program | AMEX:IRBO | |
| 28/06/2006 | 14:30 | PR Newswire (US) | NIH to Conduct Anti-microbial Evaluation of ImmuneRegen's Viprovex(TM) | AMEX:IRBO | |